{"id":54675,"date":"2023-03-09T13:03:11","date_gmt":"2023-03-09T12:03:11","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/adicet-bio-to-participate-in-2023-jefferies-biotech-on-the-bay-summit\/"},"modified":"2023-03-09T13:03:11","modified_gmt":"2023-03-09T12:03:11","slug":"adicet-bio-to-participate-in-2023-jefferies-biotech-on-the-bay-summit","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/adicet-bio-to-participate-in-2023-jefferies-biotech-on-the-bay-summit\/","title":{"rendered":"Adicet Bio to Participate in 2023 Jefferies Biotech on the Bay Summit"},"content":{"rendered":"
\n

REDWOOD CITY, Calif. & BOSTON–(BUSINESS WIRE)–Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced that Chen Schor, President and Chief Executive Officer, and Nick Harvey, Chief Financial Officer, will participate in the 2023 Jefferies Biotech on the Bay Summit being held March 16-17, 2023.\n<\/p>\n

<\/a><\/p>\n

\nThe Adicet Bio team will be available for one-on-one meetings throughout the conference. Please contact<\/a> your sales representative at Jefferies to register for a meeting with the company.\n<\/p>\n

\nAbout Adicet Bio, Inc.<\/b>\n<\/p>\n

\nAdicet Bio, Inc. is a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer. Adicet is advancing a pipeline of \u201coff-the-shelf\u201d gamma delta T cells, engineered with chimeric antigen receptors (CARs) and chimeric antigen adaptors (CAds), to enhance selective tumor targeting and facilitate innate and adaptive anti-tumor immune response for durable activity in patients. For more information, please visit our website at https:\/\/www.adicetbio.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nAdicet Bio., Inc.<\/b>
Investor and Media Contacts<\/b>\n<\/p>\n

\nAnne Bowdidge
\n
abowdidge@adicetbio.com<\/a>\n<\/p>\n

\nJanhavi Mohite
\n
Stern Investor Relations, Inc.
\n
212-362-1200
\n
janhavi.mohite@sternir.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

REDWOOD CITY, Calif. & BOSTON–(BUSINESS WIRE)–Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced that Chen Schor, President and Chief Executive Officer, and Nick Harvey, Chief Financial Officer, will participate in the 2023 Jefferies Biotech on the Bay Summit being held … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-54675","6":"format-standard","7":"category-industry"},"yoast_head":"\nAdicet Bio to Participate in 2023 Jefferies Biotech on the Bay Summit - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/adicet-bio-to-participate-in-2023-jefferies-biotech-on-the-bay-summit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Adicet Bio to Participate in 2023 Jefferies Biotech on the Bay Summit - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"REDWOOD CITY, Calif. & BOSTON–(BUSINESS WIRE)–Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced that Chen Schor, President and Chief Executive Officer, and Nick Harvey, Chief Financial Officer, will participate in the 2023 Jefferies Biotech on the Bay Summit being held ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/adicet-bio-to-participate-in-2023-jefferies-biotech-on-the-bay-summit\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-09T12:03:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230309005135\/en\/1339314\/21\/adicet_logo_500x300_%28002%29_%28004%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adicet-bio-to-participate-in-2023-jefferies-biotech-on-the-bay-summit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adicet-bio-to-participate-in-2023-jefferies-biotech-on-the-bay-summit\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Adicet Bio to Participate in 2023 Jefferies Biotech on the Bay Summit\",\"datePublished\":\"2023-03-09T12:03:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adicet-bio-to-participate-in-2023-jefferies-biotech-on-the-bay-summit\\\/\"},\"wordCount\":198,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adicet-bio-to-participate-in-2023-jefferies-biotech-on-the-bay-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230309005135\\\/en\\\/1339314\\\/21\\\/adicet_logo_500x300_%28002%29_%28004%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adicet-bio-to-participate-in-2023-jefferies-biotech-on-the-bay-summit\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adicet-bio-to-participate-in-2023-jefferies-biotech-on-the-bay-summit\\\/\",\"name\":\"Adicet Bio to Participate in 2023 Jefferies Biotech on the Bay Summit - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adicet-bio-to-participate-in-2023-jefferies-biotech-on-the-bay-summit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adicet-bio-to-participate-in-2023-jefferies-biotech-on-the-bay-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230309005135\\\/en\\\/1339314\\\/21\\\/adicet_logo_500x300_%28002%29_%28004%29.jpg\",\"datePublished\":\"2023-03-09T12:03:11+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adicet-bio-to-participate-in-2023-jefferies-biotech-on-the-bay-summit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adicet-bio-to-participate-in-2023-jefferies-biotech-on-the-bay-summit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adicet-bio-to-participate-in-2023-jefferies-biotech-on-the-bay-summit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230309005135\\\/en\\\/1339314\\\/21\\\/adicet_logo_500x300_%28002%29_%28004%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230309005135\\\/en\\\/1339314\\\/21\\\/adicet_logo_500x300_%28002%29_%28004%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adicet-bio-to-participate-in-2023-jefferies-biotech-on-the-bay-summit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Adicet Bio to Participate in 2023 Jefferies Biotech on the Bay Summit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Adicet Bio to Participate in 2023 Jefferies Biotech on the Bay Summit - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/adicet-bio-to-participate-in-2023-jefferies-biotech-on-the-bay-summit\/","og_locale":"en_US","og_type":"article","og_title":"Adicet Bio to Participate in 2023 Jefferies Biotech on the Bay Summit - Pharma Trend","og_description":"REDWOOD CITY, Calif. & BOSTON–(BUSINESS WIRE)–Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced that Chen Schor, President and Chief Executive Officer, and Nick Harvey, Chief Financial Officer, will participate in the 2023 Jefferies Biotech on the Bay Summit being held ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/adicet-bio-to-participate-in-2023-jefferies-biotech-on-the-bay-summit\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-09T12:03:11+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230309005135\/en\/1339314\/21\/adicet_logo_500x300_%28002%29_%28004%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/adicet-bio-to-participate-in-2023-jefferies-biotech-on-the-bay-summit\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/adicet-bio-to-participate-in-2023-jefferies-biotech-on-the-bay-summit\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Adicet Bio to Participate in 2023 Jefferies Biotech on the Bay Summit","datePublished":"2023-03-09T12:03:11+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/adicet-bio-to-participate-in-2023-jefferies-biotech-on-the-bay-summit\/"},"wordCount":198,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/adicet-bio-to-participate-in-2023-jefferies-biotech-on-the-bay-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230309005135\/en\/1339314\/21\/adicet_logo_500x300_%28002%29_%28004%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/adicet-bio-to-participate-in-2023-jefferies-biotech-on-the-bay-summit\/","url":"https:\/\/pharma-trend.com\/en\/adicet-bio-to-participate-in-2023-jefferies-biotech-on-the-bay-summit\/","name":"Adicet Bio to Participate in 2023 Jefferies Biotech on the Bay Summit - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/adicet-bio-to-participate-in-2023-jefferies-biotech-on-the-bay-summit\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/adicet-bio-to-participate-in-2023-jefferies-biotech-on-the-bay-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230309005135\/en\/1339314\/21\/adicet_logo_500x300_%28002%29_%28004%29.jpg","datePublished":"2023-03-09T12:03:11+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/adicet-bio-to-participate-in-2023-jefferies-biotech-on-the-bay-summit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/adicet-bio-to-participate-in-2023-jefferies-biotech-on-the-bay-summit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/adicet-bio-to-participate-in-2023-jefferies-biotech-on-the-bay-summit\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230309005135\/en\/1339314\/21\/adicet_logo_500x300_%28002%29_%28004%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230309005135\/en\/1339314\/21\/adicet_logo_500x300_%28002%29_%28004%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/adicet-bio-to-participate-in-2023-jefferies-biotech-on-the-bay-summit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Adicet Bio to Participate in 2023 Jefferies Biotech on the Bay Summit"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54675","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54675"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54675\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54675"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54675"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54675"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}